943 related articles for article (PubMed ID: 26111766)
1. SLC transporters as therapeutic targets: emerging opportunities.
Lin L; Yee SW; Kim RB; Giacomini KM
Nat Rev Drug Discov; 2015 Aug; 14(8):543-60. PubMed ID: 26111766
[TBL] [Abstract][Full Text] [Related]
2. The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics.
Li Y; Lu J; Paxton JW
Curr Drug Metab; 2012 Jun; 13(5):624-39. PubMed ID: 22475331
[TBL] [Abstract][Full Text] [Related]
3. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
Rives ML; Javitch JA; Wickenden AD
Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
[TBL] [Abstract][Full Text] [Related]
4. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
5. Beyond the ITC White Paper: emerging sciences in drug transporters and opportunities for drug development.
Lai Y; Hsiao P
Curr Pharm Des; 2014; 20(10):1577-94. PubMed ID: 23789952
[TBL] [Abstract][Full Text] [Related]
6. The biological and clinical role of drug transporters at the intestinal barrier.
Oostendorp RL; Beijnen JH; Schellens JH
Cancer Treat Rev; 2009 Apr; 35(2):137-47. PubMed ID: 18986769
[TBL] [Abstract][Full Text] [Related]
7. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs.
Scalise M; Console L; Galluccio M; Pochini L; Tonazzi A; Giangregorio N; Indiveri C
SLAS Discov; 2019 Oct; 24(9):867-881. PubMed ID: 31251685
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling and ligand docking for solute carrier (SLC) transporters.
Schlessinger A; Khuri N; Giacomini KM; Sali A
Curr Top Med Chem; 2013; 13(7):843-56. PubMed ID: 23578028
[TBL] [Abstract][Full Text] [Related]
9. Nutrient transporters: connecting cancer metabolism to therapeutic opportunities.
Nwosu ZC; Song MG; di Magliano MP; Lyssiotis CA; Kim SE
Oncogene; 2023 Mar; 42(10):711-724. PubMed ID: 36739364
[TBL] [Abstract][Full Text] [Related]
10. Role of SLC xenobiotic transporters and their regulatory mechanisms PDZ proteins in drug delivery and disposition.
Sugiura T; Kato Y; Tsuji A
J Control Release; 2006 Nov; 116(2):238-46. PubMed ID: 16876283
[TBL] [Abstract][Full Text] [Related]
11. The importance of drug transporters in human pluripotent stem cells and in early tissue differentiation.
Apáti Á; Szebényi K; Erdei Z; Várady G; Orbán TI; Sarkadi B
Expert Opin Drug Metab Toxicol; 2016; 12(1):77-92. PubMed ID: 26592535
[TBL] [Abstract][Full Text] [Related]
12. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
Dolberg AM; Reichl S
Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
[TBL] [Abstract][Full Text] [Related]
14. Transporter-Mediated Drug Delivery.
Gyimesi G; Hediger MA
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
[TBL] [Abstract][Full Text] [Related]
15. TICBase: Integrated Resource for Data on Drug and Environmental Chemical Interactions with Mammalian Drug Transporters.
Michel ME; Wen CC; Yee SW; Giacomini KM; Hamdoun A; Nicklisch SCT
Clin Pharmacol Ther; 2023 Dec; 114(6):1293-1303. PubMed ID: 37657924
[TBL] [Abstract][Full Text] [Related]
16. Studying Interactions of Drugs with Cell Membrane Nutrient Transporters: New Frontiers of Proteoliposome Nanotechnology.
Scalise M; Galluccio M; Pochini L; Console L; Barile M; Giangregorio N; Tonazzi A; Indiveri C
Curr Pharm Des; 2017; 23(26):3871-3883. PubMed ID: 28625135
[TBL] [Abstract][Full Text] [Related]
17. Phase 0 and phase III transport in various organs: combined concept of phases in xenobiotic transport and metabolism.
Döring B; Petzinger E
Drug Metab Rev; 2014 Aug; 46(3):261-82. PubMed ID: 24483608
[TBL] [Abstract][Full Text] [Related]
18. Progress of solute carrier SLC family in nonalcoholic fatty liver disease.
Tang ZQ; Shi L; Xiong J
Yi Chuan; 2022 Oct; 44(10):881-898. PubMed ID: 36384725
[TBL] [Abstract][Full Text] [Related]
19. The genetic landscape of the human solute carrier (SLC) transporter superfamily.
Schaller L; Lauschke VM
Hum Genet; 2019 Dec; 138(11-12):1359-1377. PubMed ID: 31679053
[TBL] [Abstract][Full Text] [Related]
20. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
